Edition:
United States

Aap Implantate AG (AAQG.DE)

AAQG.DE on Xetra

1.33EUR
25 May 2017
Change (% chg)

-- (--)
Prev Close
€1.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
40,335
52-wk High
€1.55
52-wk Low
€1.05

AAQG.DE

Chart for AAQG.DE

About

aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in... (more)
No analyst recommendations are available for AAQG.DE.

Overall

Beta: 0.51
Market Cap(Mil.): €41.01
Shares Outstanding(Mil.): 30.83
Dividend: --
Yield (%): --

Financials

  AAQG.DE Industry Sector
P/E (TTM): -- 31.44 17.41
EPS (TTM): -0.28 -- --
ROI: -17.88 12.84 -5.42
ROE: -19.21 15.33 -4.68

BRIEF-Integra Lifesciences Holdings Corp signs an agreement with AAP Implantate AG

* Integra Lifesciences Holdings Corp says signed an agreement with AAP Implantate AG to distribute loqteq distal radius system within United States Source text for Eikon: Further company coverage:

May 23 2017

BRIEF-aap Implantate Q1 sales up 23 pct at 3.1 million euros

* Increased total sales in Q1 of 2017 in comparison to first three months of last year by 23 pct to 3.1 million euros (Q1/2016: 2.5 million euros) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Apr 24 2017

BRIEF-aap Implantate concludes distribution agreement for LOQTEQ radius system

* Concludes distribution agreement for LOQTEQ radius system with US medical technology company Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Apr 21 2017

BRIEF-aap Implantate 2016 sales and EBITDA below guidance

* Sales by 514,000 euros ($555,993.80) and EBITDA by 450,000 euros slightly below guidance for financial year 2016 due to failure of distributor to fulfil contractual duties

Mar 21 2017

BRIEF-aap Implantate Q4 sales stable at 2.4 million euros

* Said on Tuesday achieved prelim sales of 2.4 million euros ($2.53 million) in the continued operation in the fourth quarter of 2016 (Q4/2015: 2.4 million euros)

Mar 01 2017

More From Around the Web

Earnings vs. Estimates